
New Injective ETF plans to reinvest staking rewards, boosting fund value instead of paying cash dividends.
Canary Capital proposes an Injective (INJ) ETF that reinvests staking rewards back into the fund rather than distributing cash to shareholders. The fund delegates tokens to validators on the Injective network, with staking rewards paid in INJ tokens....





